Safety

Vet-Stem Regenerative Cells--Key Safety Factors:
• Autologous (from the patient back to the same patient): Tissue reaction risk is minimized
• Minimally manipulated: Cells are not differentiated or modified
• Accurate determination of each dose
• Quality assessment of each dose
• Vet-Stem employs stringent processing protocols and quality control methods
• Hundreds of publications support the safety of autologous cell therapy in animals
• Reported canine adverse events: No systemic effects. Mild to significant local pain 0.1%
  (in the joint injected)
• Reported equine adverse events: No systemic effects. Mild to significant local inflammation 0.2%

Pet owners should discuss appropriateness of treatment for their pet including potential complications of surgery, potential outcomes, a comprehensive treatment plan and associated costs with their veterinarian prior to treatment. A checklist of points to consider can be found here.